Exparel vs Dexamethasone for Rotator Cuff Surgery Pain
Trial Summary
What is the purpose of this trial?
Effective and safe control of pain after shoulder surgery is an important component of the post-surgical process. Patients who are comfortable in the early period after surgery are more satisfied with their experience and are better able to participate in rehabilitation exercises during their stay in the hospital. As surgeons and health care systems in the United States find themselves in the middle of an opioid epidemic, it is necessary to discover different options to provide patients pain relief that are both effective and safe in an effort to decrease the amount of pain medication used.
Will I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications. However, if you have been using opioids in the 3 months before surgery, you may not be eligible to participate.
What data supports the effectiveness of the drug Exparel vs Dexamethasone for reducing pain after rotator cuff surgery?
Research shows that dexamethasone, when used with bupivacaine, can significantly prolong pain relief after surgery and reduce the incidence of severe pain when nerve blocks wear off. This suggests that combining dexamethasone with bupivacaine, as in the Exparel treatment, may effectively manage postoperative pain.12345
Is Dexamethasone safe for use in surgeries?
How does the drug Dexamethasone differ from other treatments for rotator cuff surgery pain?
Eligibility Criteria
This trial is for individuals with rotator cuff injuries who have undergone surgery. It's aimed at those seeking effective postoperative pain management without relying heavily on opioids, which can be addictive.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive a shoulder block with Liposomal bupivacaine (Exparel) or Liposomal bupivacaine combined with Dexamethasone before rotator cuff repair surgery
Follow-up
Participants are monitored for postoperative pain levels and narcotic medication use
Treatment Details
Interventions
- Bupivacaine Hcl 0.5% Inj
- Dexamethasone
- Liposomal bupivacaine
Dexamethasone is already approved in European Union, United States, Canada, Japan for the following indications:
- Inflammation
- Allergic reactions
- Respiratory diseases
- Skin conditions
- Eye diseases
- Immune system disorders
- Inflammatory conditions
- Allergic states
- Respiratory diseases
- Blood disorders
- Neoplastic diseases
- Nervous system disorders
- Inflammation
- Allergic reactions
- Respiratory diseases
- Skin conditions
- Eye diseases
- Inflammatory conditions
- Allergic states
- Respiratory diseases
- Blood disorders
Find a Clinic Near You
Who Is Running the Clinical Trial?
Rothman Institute Orthopaedics
Lead Sponsor